Stephen W Webster - Net Worth and Insider Trading
Stephen W Webster Net Worth
The estimated net worth of Stephen W Webster is at least $731,845 dollars as of 2024-06-09. Stephen W Webster is the Director of Viking Therapeutics Inc and owns about 8,000 shares of Viking Therapeutics Inc (VKTX) stock worth over $447,920. Stephen W Webster is the CFO of Spark Therapeutics Inc and owns about 2,500 shares of Spark Therapeutics Inc (ONCE) stock worth over $283,925. Stephen W Webster is also the Director of Nabriva Therapeutics PLC and owns about 458 shares of Nabriva Therapeutics PLC (NBRVF) stock worth over $0. Details can be seen in Stephen W Webster's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephen W Webster has not made any transactions after 2022-08-02 and currently still holds the listed stock(s).
Transaction Summary of Stephen W Webster
Stephen W Webster Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen W Webster owns 6 companies in total, including Nabriva Therapeutics PLC (NBRVF) , NextCure Inc (NXTC) , and TCR2 Therapeutics Inc (TCRR) among others .
Click here to see the complete history of Stephen W Webster’s form 4 insider trades.
Insider Ownership Summary of Stephen W Webster
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NBRVF | Nabriva Therapeutics PLC | 2022-08-02 | director |
NXTC | NextCure Inc | 2019-05-08 | director |
TCRR | TCR2 Therapeutics Inc | 2020-12-10 | director |
2018-05-29 | director | ||
2019-12-17 | CHIEF FINANCIAL OFFICER | ||
2021-01-07 | director |
Stephen W Webster Latest Holdings Summary
Stephen W Webster currently owns a total of 3 stocks. Among these stocks, Stephen W Webster owns 8,000 shares of Viking Therapeutics Inc (VKTX) as of May 29, 2018, with a value of $447,920 and a weighting of 61.2%. Stephen W Webster owns 2,500 shares of Spark Therapeutics Inc (ONCE) as of November 16, 2017, with a value of $283,925 and a weighting of 38.8%. Stephen W Webster also owns 458 shares of Nabriva Therapeutics PLC (NBRVF) as of August 2, 2022, with a value of $0 and a weighting of 0%.
Latest Holdings of Stephen W Webster
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
VKTX | Viking Therapeutics Inc | 2018-05-29 | 8,000 | 55.99 | 447,920 |
ONCE | Spark Therapeutics Inc | 2017-11-16 | 2,500 | 113.57 | 283,925 |
NBRVF | Nabriva Therapeutics PLC | 2022-08-02 | 458 | 0.00 | 0 |
Holding Weightings of Stephen W Webster
Stephen W Webster Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen W Webster has made a total of 0 transactions in Viking Therapeutics Inc (VKTX) over the past 5 years. The most-recent trade in Viking Therapeutics Inc is the acquisition of 8,000 shares on May 29, 2018, which cost Stephen W Webster around $41,680.
According to the SEC Form 4 filings, Stephen W Webster has made a total of 0 transactions in Spark Therapeutics Inc (ONCE) over the past 5 years. The most-recent trade in Spark Therapeutics Inc is the sale of 10,000 shares on November 16, 2017, which brought Stephen W Webster around $701,400.
According to the SEC Form 4 filings, Stephen W Webster has made a total of 2 transactions in Nabriva Therapeutics PLC (NBRVF) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Nabriva Therapeutics PLC is the sale of 313 shares on August 2, 2022, which brought Stephen W Webster around $1,487.
Insider Trading History of Stephen W Webster
- 1
Stephen W Webster Trading Performance
GuruFocus tracks the stock performance after each of Stephen W Webster's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen W Webster is 45.02%. GuruFocus also compares Stephen W Webster's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen W Webster within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen W Webster's insider trading performs compared to the benchmark.
Performance of Stephen W Webster
Stephen W Webster Ownership Network
Ownership Network List of Stephen W Webster
Ownership Network Relation of Stephen W Webster
Stephen W Webster Owned Company Details
What does Nabriva Therapeutics PLC do?
Who are the key executives at Nabriva Therapeutics PLC?
Stephen W Webster is the director of Nabriva Therapeutics PLC. Other key executives at Nabriva Therapeutics PLC include Chief Executive Officer Hogan H Michael Iii , Chief Financial Officer David Maggio , and Chief Executive Officer Broom Colin Md .
Nabriva Therapeutics PLC (NBRVF) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Nabriva Therapeutics PLC (NBRVF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nabriva Therapeutics PLC (NBRVF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Nabriva Therapeutics PLC (NBRVF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nabriva Therapeutics PLC Insider Transactions
Stephen W Webster Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen W Webster. You might contact Stephen W Webster via mailing address: C/o Optimer Pharmaceuticals, Inc, 101 Hudson Street, San Diego Ca 07302.